Supplement regulation in Australia

Reading AU supplement labels: AUST L vs AUST R, and what they mean

Australian supplements carry one of two markings: AUST L (Listed) or AUST R (Registered).

AUST L products self-certify against TGA-permitted indications, assessed for safety and quality but NOT for clinical efficacy. Most vitamins, herbal supplements, and minerals on AU shelves are AUST L.

AUST R products have been individually assessed by TGA for safety, quality, AND efficacy. Prescription medicines and most OTC analgesics are AUST R.

Practical implication: AUST L = TGA-aware, not TGA-validated for efficacy. Most adults are taking AUST L supplements — a regulatory fact, not a statement that the product works.

What the labels mean — fundamentals first

In Australia, every legally-sold therapeutic supplement carries a marking on the Australian Register of Therapeutic Goods (ARTG). The two main classes for supplements:

AUST L — Listed

  • Lower-risk products
  • TGA-permitted ingredients only (from a defined list)
  • Sponsor self-certifies the product meets manufacturing and quality standards
  • Claims must be from a TGA-permitted indication list
  • TGA does NOT individually pre-assess each product for efficacy
  • Most vitamins, minerals, herbal supplements

AUST R — Registered

  • Higher-risk or higher-claim products
  • TGA individually evaluates safety, quality, AND efficacy for the stated indication
  • Required clinical evidence for the specific product in its specific use
  • All prescription medicines
  • Most over-the-counter analgesics (paracetamol, ibuprofen, etc.)
  • A smaller number of complementary medicines that have completed full registration

The crucial implication: AUST L tells you the regulator has been notified, the manufacturing meets standards, and the claims use TGA-permitted wording. It does NOT tell you the specific product has been clinically validated for the implied benefit.

The TGA’s permitted-indications list is what shapes AUST L marketing language. Sponsors choose from this list when registering. The list uses phrases like “supports immune function”, “maintains general wellbeing”, “may help reduce occasional symptoms of…”. The wording is deliberately gentle — sponsors can’t claim cure, prevention, or treatment of serious disease.

A. Core clinical — how AU general practice engages with supplements

The AU clinical context:

NPS MedicineWise maintains AU-specific decision-support resources on complementary medicines, including major interaction warnings (St John’s wort with many prescription medications, ginkgo with antiplatelets, kava liver risk).

The Australian Medicines Handbook (AMH) covers some complementary medicines with the same clinical-detail format as prescription drugs — useful when a patient asks about an interaction.

RACGP position is to support patient choice in complementary-medicine use, while taking active history of all supplements (including over-the-counter and imported) at every long consultation, and screening for interactions with prescription medication or planned procedures.

Choosing Wisely Australia flags some specific scenarios where supplementation lacks evidence, e.g. routine multivitamins in non-deficient adults for general health, vitamin D in non-deficient adults without specific indication.

Supplements with consistent AU primary-tier evidence (in appropriate contexts):

  • Iron in iron-deficient adults (especially menstruating women)
  • Vitamin B12 in confirmed deficiency or strict vegan diets
  • Folate during pregnancy planning and first trimester
  • Vitamin D in confirmed deficiency
  • Calcium in postmenopausal women at osteoporosis risk where dietary intake is inadequate
  • Iodine during pregnancy planning and pregnancy
  • Omega-3 (EPA-dominant) as adjunct in major depressive disorder per Cochrane evidence

Supplements widely marketed with weak AU primary-tier evidence:

  • Multivitamins in healthy non-deficient adults
  • High-dose antioxidants in adults eating a varied diet
  • “Cleanse” / “detox” supplements
  • “Adrenal support” supplements (the underlying concept isn’t a recognised diagnosis)
  • Hair / nail / skin “support” supplements at the doses typically marketed
  • High-dose vitamin C for cold prevention
  • Most weight-loss supplements

The pattern that distinguishes the two groups: the first group is supplementing a measurable, treatable physiological deficiency; the second is marketed for general wellness or imprecise complaints in non-deficient adults.

B. How to read a label and what to look for

A reasonable due-diligence routine before buying a supplement:

1. Find the AUST number. Usually small text on the packaging. Search the ARTG database using that number.

2. Read the TGA-permitted indication. This is the wording the TGA approved for use. It is often narrower than the marketing claim on the front of the box.

3. Identify the active ingredient and dose. The “Active ingredients” section. Compare the dose against:

4. Check for interactions. Especially important if you’re on any prescription medication, planning surgery, pregnant, or breastfeeding. AMH and NPS are the AU primary tier.

5. Look at the inactive ingredients. Capsule gelatin (animal vs vegetable origin), allergens (lactose, gluten, soy, sulfites), and excipients matter for some patients.

6. Check the sponsor (the company holding the AUST registration). Larger AU sponsors with a long compliance history are typically lower-risk than newer brands. The TGA publishes a list of recently-suspended or cancelled listings.

7. Sportspeople — check the supplement against Sport Integrity Australia anti-doping resources. Many AUST L supplements contain ingredients prohibited in elite sport, and many have been linked to contamination producing positive tests.

C. AU regulatory action and consumer protection

Several active mechanisms protect consumers:

TGA Advertising compliance acts on off-label or unauthorised therapeutic claims. Public enforcement actions are listed on the TGA website.

ACCC consumer protection acts under Australian Consumer Law for misleading claims. Recent action has been taken against multiple supplement brands for unsubstantiated claims.

Pharmacy Board / Medical Board apply to professional advertising — practitioners cannot make unsubstantiated therapeutic claims about supplements they sell or recommend.

Sport Integrity Australia maintains the AU-specific anti-doping resource, including a list of supplements flagged for contamination with WADA-prohibited substances. Useful as a contamination-risk reference for athletes.

Adverse event reporting — anyone (consumer, pharmacist, GP) can report a suspected adverse event to the TGA’s Database of Adverse Event Notifications. The database is searchable.

(MBS / PBS items verified 2026-05-16 via WebSearch — workspace egress to mbsonline.gov.au + pbs.gov.au still blocked; spot-check confirms current. Note that supplements are not PBS-listed except in rare prescription-only cases.)

D. Practical framework

For an adult considering a specific supplement:

StepWhat
1. Is there a documented deficiency?Iron studies, B12, folate, vitamin D, etc. via GP bloods. If yes → replacement is supported. If no → reconsider the rationale.
2. Is the marketed claim aligned with the TGA-permitted indication?Check ARTG. The two should match; if marketing is broader, treat with caution.
3. Is there peer-reviewed evidence for this specific product in your specific situation?Search PubMed, NPS, Cochrane. Not “is vitamin X useful” — “is THIS supplement, at THIS dose, in MY situation, evidence-supported?“
4. Are there interactions or contraindications?Check AMH and NPS against your current medication list, pregnancy status, planned procedures.
5. What’s the cost-benefit?AUD $30–50/month on a supplement that lacks trial support is a meaningful amount that could fund evidence-led care.
6. Is there a deprescribing endpoint?Most supplements should have a review window — 3 months for a trial, then assess.

Examples where AU primary tier supports supplementation:

  • Iron in confirmed iron-deficiency anaemia
  • Vitamin B12 in confirmed deficiency (especially older adults, vegans, post-bariatric surgery)
  • Vitamin D in confirmed deficiency
  • Folate and iodine during pregnancy planning and pregnancy
  • Calcium in postmenopausal women with inadequate dietary intake and osteoporosis risk
  • Omega-3 (EPA-dominant) as adjunct in major depressive disorder

Examples where AU primary tier does not support routine supplementation:

  • Multivitamins in healthy adults with no documented deficiency
  • High-dose vitamin C for cold prevention
  • “Detox” or “cleanse” protocols
  • “Adrenal support” supplements
  • Routine zinc, selenium, or antioxidant supplementation in non-deficient adults
  • High-dose vitamin E (associated with increased mortality in some cohorts)

What this article is and is not

This is general health information drawn from the current Australian TGA regulatory framework, AMH, NPS MedicineWise, RACGP positions, Choosing Wisely Australia, and AU consumer-protection mechanisms. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about whether a specific supplement is appropriate for a specific situation are made with your own GP, pharmacist, or accredited practising dietitian.

For Australian consumer-friendly sources: HealthDirect — Complementary medicines, TGA Consumer Information, NPS MedicineWise.


Sources cited

  1. TGA — Listed and Registered medicines
  2. TGA — Australian Register of Therapeutic Goods (ARTG)
  3. TGA — Advertising therapeutic goods
  4. TGA — Permitted indications for listed medicines
  5. ACCC — Health products and services
  6. Australian Medicines Handbook
  7. NPS MedicineWise — Complementary medicines
  8. RACGP
  9. HealthDirect — Complementary medicines
  10. Choosing Wisely Australia
  11. NHMRC — Nutrient Reference Values
  12. Sport Integrity Australia

Frequently asked questions

  • What is the difference between AUST L and AUST R on a supplement bottle?

    AUST L (Listed) and AUST R (Registered) are the two main classes of therapeutic-goods inclusion on the Australian Register of Therapeutic Goods (ARTG). AUST L applies to lower-risk products (most vitamins, minerals, herbal supplements). Sponsors self-certify the product meets manufacturing standards and uses only TGA-permitted indications. The TGA does not pre-assess each product for clinical efficacy. AUST R applies to higher-risk products and to products making more specific therapeutic claims. The TGA individually evaluates safety, quality, AND efficacy for the stated indication. Prescription medicines are typically AUST R. The marking appears on every legitimate AU supplement bottle.

  • Does AUST L mean the supplement works?

    Not necessarily. AUST L confirms the TGA has been notified about the product, the ingredients are from a TGA-permitted list, the manufacturing meets standards, and the claims are from a TGA-permitted indication list. It does NOT confirm the specific product has been clinically tested for efficacy. Many AUST L supplements have weak or no trial evidence for the indications they imply. The marking provides regulatory assurance about safety and quality control, not clinical evidence for benefit.

  • How do I find an AUST L or AUST R product on the ARTG?

    Search the TGA's public ARTG database at tga.gov.au using the AUST number (e.g. AUST L 12345). The listing shows: sponsor (company holding the registration), permitted indications, active ingredients with declared quantities, and any TGA-flagged compliance issues. Worth checking before buying any supplement marketed with broad health claims — the actual TGA-permitted indication is often narrower than the marketing.

  • Are imported supplements (e.g. from US iHerb) regulated by TGA?

    No. Supplements purchased from overseas for personal import are not subject to AU regulatory oversight. Some imported products contain ingredients banned in Australia (certain herbs, undeclared pharmaceuticals, contamination with heavy metals or pesticides). Personal-importation rules apply (TGA personal-import scheme — limited quantity, personal use, declared); commercial import for resale requires ARTG inclusion. The TGA periodically publishes warnings about specific imported products found to contain undeclared ingredients.

  • What clinical claims are AUST L sponsors NOT allowed to make?

    AUST L products cannot claim to treat, cure, or prevent a serious form of disease (cancer, cardiovascular disease, diabetes, mental illness, infectious disease, etc.). They can make 'maintains', 'supports', or 'assists' claims aligned with the TGA-permitted indications list (e.g. 'supports immune function', 'maintains general wellbeing', 'assists healthy digestion'). The wording matters: a supplement that 'supports immune function' is not a supplement that prevents flu. The TGA Advertising compliance unit and the ACCC both take action against off-label therapeutic claims.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.